Cannabis
CBD of Denver Reports November 2021 Revenue of $1M (USD) and 37% Increase in Number of Wholesale Transactions
Denver, Colorado–(Newsfile Corp. – December 15, 2021) – CBD of Denver, Inc. (OTC Pink: CBDD), a cultivator and distributor of CBD and cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe, is pleased to report a 37% year-over-year increase in the number of wholesale transactions for the month of November for its Rockflowr business. The 59 transactions completed in November were for a total of 913 kilograms, generating $1.0 million (USD) in revenue, with margins improving to 7.3%, up from 6.7% in the same period of 2020.
The Company’s strong performance prompted its move to a larger location. The new modern 1000 square meter facility is located in Zürich very close to the airport, with ample client parking and office space for sales personnel, management, and accounting. An important feature of the new facility is its large climate-controlled warehouse. In preparation for further growth, the Company has also hired additional sales staff for Italy and France as well as an analytics manager and facility manager. In addition to supporting increasing margins through improved efficiencies, the new location will allow for a seamless transition to cannabis distribution as legalization efforts move forward.
“I am very proud of our sales staff and their efforts to increase sales. Our new climate-controlled warehouse is perfect for our current inventory and gives us room to grow. I am very pleased with our direction and future,” commented Marcel Gamma, CEO.
Watch for future Press Releases, we have some interesting information to share regarding the legalization of Cannabis and Marijuana products.
Follow CBDD on Instagram: @SwissCBDTrading @Rockflowr @CBDofDenver_Inc @SwissGreenGrow @RockflowrRetail
CBD of Denver, Inc., Rockflowr GmbH and Swiss Industry Ventures AG are now also on LinkedIn.
About CBD of Denver, Inc.
CBD of Denver, Inc. (OTC Pink: CBDD) a full-line Cultivator, Distributor of CBD and Cannabis flower and a producer of a full line of CBD oil and unique products sold in Switzerland and throughout Europe. CBD of Denver, Inc. is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for all our shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis. Through our Rockflowr brands we have built a very strong European customer base by focusing on top quality products and meaningful customer relationships.
Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and you should not place undue reliance on these statements. Any forward-looking statement reflects our current views with respect to future events. We assume no obligation publicly about update or revise these forward-looking statements for any reason.
Contacts:
Nicholas Sprung
[email protected]
Todd McKnight
RedChip Companies
1-800-733-2447
[email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/107705
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE2 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis23 hours ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt19 hours ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace